Abstract:To evaluate the effects of different endometrial preparations on the outcomes of frozen embryo transfer (FET) cycles of in vitro fertilization (IVF)/intracytoplasmic sperm injection (ICSI). Strictly controlled retrospective cohort study. Women undergoing 31,871 FET cycles of IVF/ICSI in the period between March 2003 and May 2015 were enrolled, and those with uterine abnormities, uterine disorders or disorder history, uterine or uterine cavity surgery and other conditions that were not suitable for matching were excluded. After that, women undergoing different endometrial preparations including natural cycles, hormone therapy cycles and stimulated cycles were strictly matched by age, number of cycles, number of prior full-term births, type of infertility, presence of Fallopian tubal diseases, previous Fallopian tubal surgery, previous ectopic pregnancy, polycystic ovary syndrome, endometriosis and male factor infertility, number of embryos transferred, stage of embryos transferred and endometrial thickness on embryo transfer (ET) day, and then divided into three groups according to the type of endometrial preparations: natural cycle group (n=4,098 FETs), hormone therapy cycle group (n=4,098 FETs) and stimulated cycle group (n=4,098 FETs). Statistical analyses were carried out by SPSS version 19.0. The normality of quantitative data was tested both by Kolmogorov-Smirnova test and Shapiro-Wilk test, and the Mann-Whitney U test, Chi-square test or Fisher's exact test were applied to obtain group comparisons as appropriate. P<0.05 was considered statistically significant. Main baseline characteristics including age, body mass index, number of cycles, number of prior full-term births, profiles of type of infertility, indications for IVF/ICSI and preexisting conditions including previous Fallopian tubal surgery and previous ectopic pregnancy, and FET characteristics including number of embryos transferred, number of good-quality embryos transferred, stage of embryos transferred and endometrial thickness on ET day had no statistically significant differences among the three groups. As for pregnancy outcome, the ectopic pregnancy rates and miscarriage rates also had no statistically significant differences among the three groups. However, the clinical pregnancy rate (47.6% vs. 44.0%, p=0.001, 47.6% vs. 43.3%, p<0.001, respectively) and live birth delivery rate (31.1% vs. 28.2%, p=0.004, 31.1% vs.26.4%, p<0.001, respectively) were statistically significant higher in stimulated cycle group both than in natural cycle group and in hormone therapy cycle group while no statistically significant differences were detected between the latter two groups. Stimulated cycles are associated with significant higher clinical pregnancy rate and live birth delivery rate both than natural cycles and hormone therapy cycles in FET cycles of IVF/ICSI.

The decrease of E2 (serum estradiol) level at day four after ET (embryo transfer) means something in FTET (Frozen-thawed ET) cycles

A Comparison of Implantation, Miscarriage and Pregnancy Rates of Single and Double Day 3 Embryo Transfer Between Fresh and Frozen Thawed Transfer Cycles: a Retrospective Study.

[Frozen-Thawed Embryo Transfer (FET) Versus Fresh Embryo Transfer in Clinical Pregnancy Rate During in Vitro Fertilization-Embryo Transfer].

THE RELATIONSHIP BETWEEN SERUM ESTROGEN (E2) LEVELS AND OUTCOMES OF HORMONE REPLACEMENT THERAPY-FROZEN EMBRYO TRANSFER (HRT-FET).

The effect of progesterone level prior to oocyte retrieval on the numbers of oocytes retrieved and embryo quality in IVF treatment cycles: an analysis of 2,978 cycles

The effect of different estradiol concentrations on the day of HCG administration on pregnancy outcome of fresh IVF cycles and subsequent frozen-thawed embryo transfer cycles

Estradiol change after HCG administration and clinical outcome in IVF long protocol ovulation induction cycle

Analysis of Decreased Serum Estradiol Level after Human Chorionic Gonadotropin Administration During Controlled Ovarian Hyperstimulation

Effect of serum estradiol and progesterone level and progesterone/estradiol ratio on the day of human chorionic gonadotropin administration in pregnancy outcome of in vitro fertilization-embryo transplantation

Effect of Endometrial Thickness Change in Response to Progesterone Administration on Pregnancy Outcomes in Frozen-Thawed Embryo Transfer: Analysis of 4465 Cycles

The Relationship Between Serum Oestrogen Levels and Clinical Outcomes of Hormone Replacement Therapy-Frozen Embryo Transfer: a Retrospective Clinical Study.

Roles of estradiol levels on the day of human chorionic gonadotrophin administration in the live birth of patients with frozen embryo transfer

The influence of progesterone and estradiol level on the day on clinical outcome of frozen thawed embryo transfer in nature cycle.

Serum Estradiol Level and Progesterone/Estradiol Ratio Per Follicle on HCG Administration Day in Relation to Outcomes of in Vitro Fertilization and Embryo Transfer

The influence of low-dose estradiol supplementation during the luteal phase on the clinical outcome of in vitro fertilization and embryo transfer

Association Between Serum Estradiol Level on the Human Chorionic Gonadotrophin Administration Day and Clinical Outcome.

Estradiol on Trigger Day: Irrelevant to Live Birth Rates of Fresh Cycles but Positively Associated with Cumulative Live Birth Rates.

Effects of serum estrogen levels before frozen-thawed blastocyst transfer on pregnancy outcomes in hormone replacement cycles

Decreased endometrial thickness between HCG day and embryo transfer day improves the pregnancy rate of IVF/ICSI cycles

Significance of Endometrial Thickness Change after Human Chorionic Gonadotrophin Triggering in Modified Natural Cycles for Frozen-Thawed Embryo Transfer

Effects of Different Endometrial Preparations on the Outcomes of Frozen Embryo Transfer Cycles of in Vitro Fertilization/Intracytoplasmic Sperm Injection: A Study Based on More Than 30,000 Cycles.